EXAS

Exact Sciences Corporation is a leading innovator in the field of cancer diagnostics, focused on improving early detection and treatment efficacy through advanced screening and diagnostic solutions. Headquartered in Madison, Wisconsin, the company has gained prominence for its flagship product, Cologuard, which revolutionizes colorectal cancer screening by enabling non-invasive testing methods. Committed to transforming cancer care, Exact Sciences leverages cutting-edge technology and extensive research capabilities to expand its portfolio and enhance patient outcomes, positioning itself as a key player in the healthcare sector.